Summary

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.

According to APO Research, The global Glycomics & Glycobiology market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.





Report Includes
This report presents an overview of global market for Glycomics & Glycobiology, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Glycomics & Glycobiology, also provides the revenue of main regions and countries. Of the upcoming market potential for Glycomics & Glycobiology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glycomics & Glycobiology revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Glycomics & Glycobiology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Glycomics & Glycobiology revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, Takara Bio, Inc., Agilent Technologies, Bruker, Promega and Waters Corporation, etc.

Glycomics & Glycobiology segment by Company
ThermoFisher Scientific
Danaher
Shimadzu Corporation
ProZyme
Takara Bio, Inc.
Agilent Technologies
Bruker
Promega
Waters Corporation
R&D Systems
New England Biolabs
Merck KGaA

Glycomics & Glycobiology segment by Type
Instruments
Enzymes
Reagents
Kits

Glycomics & Glycobiology segment by Application
Drug Discovery & Development
Diagnostics
Others

Glycomics & Glycobiology segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycomics & Glycobiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycomics & Glycobiology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycomics & Glycobiology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Glycomics & Glycobiology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Glycomics & Glycobiology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glycomics & Glycobiology revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Chapter 13: The main concluding insights of the report.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Product Definition
1.2 Glycomics & Glycobiology Market by Type
1.2.1 Global Glycomics & Glycobiology Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Enzymes
1.2.4 Reagents
1.2.5 Kits
1.3 Glycomics & Glycobiology Market by Application
1.3.1 Global Glycomics & Glycobiology Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Drug Discovery & Development
1.3.3 Diagnostics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives

2 Glycomics & Glycobiology Market Dynamics
2.1 Glycomics & Glycobiology Industry Trends
2.2 Glycomics & Glycobiology Industry Drivers
2.3 Glycomics & Glycobiology Industry Opportunities and Challenges
2.4 Glycomics & Glycobiology Industry Restraints

3 Global Growth Perspective
3.1 Global Glycomics & Glycobiology Market Perspective (2019-2030)
3.2 Global Glycomics & Glycobiology Growth Trends by Region
3.2.1 Global Glycomics & Glycobiology Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Glycomics & Glycobiology Market Size by Region (2019-2024)
3.2.3 Global Glycomics & Glycobiology Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Glycomics & Glycobiology Revenue by Players
4.1.1 Global Glycomics & Glycobiology Revenue by Players (2019-2024)
4.1.2 Global Glycomics & Glycobiology Revenue Market Share by Players (2019-2024)
4.1.3 Global Glycomics & Glycobiology Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Glycomics & Glycobiology Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Glycomics & Glycobiology Key Players Headquarters & Area Served
4.4 Global Glycomics & Glycobiology Players, Product Type & Application
4.5 Global Glycomics & Glycobiology Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Glycomics & Glycobiology Market CR5 and HHI
4.6.2 Global Top 5 and 10 Glycomics & Glycobiology Players Market Share by Revenue in 2023
4.6.3 2023 Glycomics & Glycobiology Tier 1, Tier 2, and Tier 3

5 Glycomics & Glycobiology Market Size by Type
5.1 Global Glycomics & Glycobiology Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Glycomics & Glycobiology Revenue by Type (2019-2030)
5.3 Global Glycomics & Glycobiology Revenue Market Share by Type (2019-2030)

6 Glycomics & Glycobiology Market Size by Application
6.1 Global Glycomics & Glycobiology Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Glycomics & Glycobiology Revenue by Application (2019-2030)
6.3 Global Glycomics & Glycobiology Revenue Market Share by Application (2019-2030)

7 Company Profiles
7.1 ThermoFisher Scientific
7.1.1 ThermoFisher Scientific Comapny Information
7.1.2 ThermoFisher Scientific Business Overview
7.1.3 ThermoFisher Scientific Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.1.4 ThermoFisher Scientific Glycomics & Glycobiology Product Portfolio
7.1.5 ThermoFisher Scientific Recent Developments
7.2 Danaher
7.2.1 Danaher Comapny Information
7.2.2 Danaher Business Overview
7.2.3 Danaher Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.2.4 Danaher Glycomics & Glycobiology Product Portfolio
7.2.5 Danaher Recent Developments
7.3 Shimadzu Corporation
7.3.1 Shimadzu Corporation Comapny Information
7.3.2 Shimadzu Corporation Business Overview
7.3.3 Shimadzu Corporation Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.3.4 Shimadzu Corporation Glycomics & Glycobiology Product Portfolio
7.3.5 Shimadzu Corporation Recent Developments
7.4 ProZyme
7.4.1 ProZyme Comapny Information
7.4.2 ProZyme Business Overview
7.4.3 ProZyme Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.4.4 ProZyme Glycomics & Glycobiology Product Portfolio
7.4.5 ProZyme Recent Developments
7.5 Takara Bio, Inc.
7.5.1 Takara Bio, Inc. Comapny Information
7.5.2 Takara Bio, Inc. Business Overview
7.5.3 Takara Bio, Inc. Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.5.4 Takara Bio, Inc. Glycomics & Glycobiology Product Portfolio
7.5.5 Takara Bio, Inc. Recent Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Comapny Information
7.6.2 Agilent Technologies Business Overview
7.6.3 Agilent Technologies Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.6.4 Agilent Technologies Glycomics & Glycobiology Product Portfolio
7.6.5 Agilent Technologies Recent Developments
7.7 Bruker
7.7.1 Bruker Comapny Information
7.7.2 Bruker Business Overview
7.7.3 Bruker Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.7.4 Bruker Glycomics & Glycobiology Product Portfolio
7.7.5 Bruker Recent Developments
7.8 Promega
7.8.1 Promega Comapny Information
7.8.2 Promega Business Overview
7.8.3 Promega Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.8.4 Promega Glycomics & Glycobiology Product Portfolio
7.8.5 Promega Recent Developments
7.9 Waters Corporation
7.9.1 Waters Corporation Comapny Information
7.9.2 Waters Corporation Business Overview
7.9.3 Waters Corporation Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.9.4 Waters Corporation Glycomics & Glycobiology Product Portfolio
7.9.5 Waters Corporation Recent Developments
7.10 R&D Systems
7.10.1 R&D Systems Comapny Information
7.10.2 R&D Systems Business Overview
7.10.3 R&D Systems Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.10.4 R&D Systems Glycomics & Glycobiology Product Portfolio
7.10.5 R&D Systems Recent Developments
7.11 New England Biolabs
7.11.1 New England Biolabs Comapny Information
7.11.2 New England Biolabs Business Overview
7.11.3 New England Biolabs Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.11.4 New England Biolabs Glycomics & Glycobiology Product Portfolio
7.11.5 New England Biolabs Recent Developments
7.12 Merck KGaA
7.12.1 Merck KGaA Comapny Information
7.12.2 Merck KGaA Business Overview
7.12.3 Merck KGaA Glycomics & Glycobiology Revenue and Gross Margin (2019-2024)
7.12.4 Merck KGaA Glycomics & Glycobiology Product Portfolio
7.12.5 Merck KGaA Recent Developments
8 North America
8.1 North America Glycomics & Glycobiology Revenue (2019-2030)
8.2 North America Glycomics & Glycobiology Revenue by Type (2019-2030)
8.2.1 North America Glycomics & Glycobiology Revenue by Type (2019-2024)
8.2.2 North America Glycomics & Glycobiology Revenue by Type (2025-2030)
8.3 North America Glycomics & Glycobiology Revenue Share by Type (2019-2030)
8.4 North America Glycomics & Glycobiology Revenue by Application (2019-2030)
8.4.1 North America Glycomics & Glycobiology Revenue by Application (2019-2024)
8.4.2 North America Glycomics & Glycobiology Revenue by Application (2025-2030)
8.5 North America Glycomics & Glycobiology Revenue Share by Application (2019-2030)
8.6 North America Glycomics & Glycobiology Revenue by Country
8.6.1 North America Glycomics & Glycobiology Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Glycomics & Glycobiology Revenue by Country (2019-2024)
8.6.3 North America Glycomics & Glycobiology Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada

9 Europe
9.1 Europe Glycomics & Glycobiology Revenue (2019-2030)
9.2 Europe Glycomics & Glycobiology Revenue by Type (2019-2030)
9.2.1 Europe Glycomics & Glycobiology Revenue by Type (2019-2024)
9.2.2 Europe Glycomics & Glycobiology Revenue by Type (2025-2030)
9.3 Europe Glycomics & Glycobiology Revenue Share by Type (2019-2030)
9.4 Europe Glycomics & Glycobiology Revenue by Application (2019-2030)
9.4.1 Europe Glycomics & Glycobiology Revenue by Application (2019-2024)
9.4.2 Europe Glycomics & Glycobiology Revenue by Application (2025-2030)
9.5 Europe Glycomics & Glycobiology Revenue Share by Application (2019-2030)
9.6 Europe Glycomics & Glycobiology Revenue by Country
9.6.1 Europe Glycomics & Glycobiology Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Glycomics & Glycobiology Revenue by Country (2019-2024)
9.6.3 Europe Glycomics & Glycobiology Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia

10 China
10.1 China Glycomics & Glycobiology Revenue (2019-2030)
10.2 China Glycomics & Glycobiology Revenue by Type (2019-2030)
10.2.1 China Glycomics & Glycobiology Revenue by Type (2019-2024)
10.2.2 China Glycomics & Glycobiology Revenue by Type (2025-2030)
10.3 China Glycomics & Glycobiology Revenue Share by Type (2019-2030)
10.4 China Glycomics & Glycobiology Revenue by Application (2019-2030)
10.4.1 China Glycomics & Glycobiology Revenue by Application (2019-2024)
10.4.2 China Glycomics & Glycobiology Revenue by Application (2025-2030)
10.5 China Glycomics & Glycobiology Revenue Share by Application (2019-2030)

11 Asia (Excluding China)
11.1 Asia Glycomics & Glycobiology Revenue (2019-2030)
11.2 Asia Glycomics & Glycobiology Revenue by Type (2019-2030)
11.2.1 Asia Glycomics & Glycobiology Revenue by Type (2019-2024)
11.2.2 Asia Glycomics & Glycobiology Revenue by Type (2025-2030)
11.3 Asia Glycomics & Glycobiology Revenue Share by Type (2019-2030)
11.4 Asia Glycomics & Glycobiology Revenue by Application (2019-2030)
11.4.1 Asia Glycomics & Glycobiology Revenue by Application (2019-2024)
11.4.2 Asia Glycomics & Glycobiology Revenue by Application (2025-2030)
11.5 Asia Glycomics & Glycobiology Revenue Share by Application (2019-2030)
11.6 Asia Glycomics & Glycobiology Revenue by Country
11.6.1 Asia Glycomics & Glycobiology Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Glycomics & Glycobiology Revenue by Country (2019-2024)
11.6.3 Asia Glycomics & Glycobiology Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia

12 Middle East, Africa, Latin America
12.1 MEALA Glycomics & Glycobiology Revenue (2019-2030)
12.2 MEALA Glycomics & Glycobiology Revenue by Type (2019-2030)
12.2.1 MEALA Glycomics & Glycobiology Revenue by Type (2019-2024)
12.2.2 MEALA Glycomics & Glycobiology Revenue by Type (2025-2030)
12.3 MEALA Glycomics & Glycobiology Revenue Share by Type (2019-2030)
12.4 MEALA Glycomics & Glycobiology Revenue by Application (2019-2030)
12.4.1 MEALA Glycomics & Glycobiology Revenue by Application (2019-2024)
12.4.2 MEALA Glycomics & Glycobiology Revenue by Application (2025-2030)
12.5 MEALA Glycomics & Glycobiology Revenue Share by Application (2019-2030)
12.6 MEALA Glycomics & Glycobiology Revenue by Country
12.6.1 MEALA Glycomics & Glycobiology Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Glycomics & Glycobiology Revenue by Country (2019-2024)
12.6.3 MEALA Glycomics & Glycobiology Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE

13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer